European Parliament votes in favor of updated pharma legislation, prompting mixed reactions; Drug shortages reached a record high as 2023 drew to a close

Taking stock of the drug industry, from the lab to the medicine chest

April 11, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Sean Gallup/Getty Images STAT+ | European Parliament votes in favor of updated pharma legislation, prompting mixed reactions The European Consumer Organization complained the effort does not go far enough to make meaningful changes. By Ed Silverman STAT+ | Drug shortages reached a record high as 2023 drew to a close "I think things will get worse before they get better," said Erin Fox, the director of the University of Utah Drug Information Service. By Ed Silverman STAT+ | Regeneron accused by Justice Department of manipulating Medicare pricing The Justice Department claims Regeneron greatly inflated the costs of its drug to Medicare over many years and enhanced its revenues. By Ed Silverman Illustration: Alex Hogan/STAT; Photo: Eisai via AP STAT+ | Medicare expects to spend $3.5 billion on new Alzheimer's drug in 2025 Medicare projections on spending for new Alzheimer's drug outpaces estimates from Wall Street and the drug manufacturers Eisai, Biogen. By Bob Herman and Rachel Cohrs Zhang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser